Peripheral neuropathy in an adolescent treated with linezolid

Pediatric Infectious Disease Journal

Volumn 28, Issue 2, 2009, Pages 149-151

  Linam, W Matthew ^a   Wesselkamper, Kristen ^a   Gerber, Michael A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Adverse effect; Child; Linezolid; Neuropathy

Indexed keywords

CEFTRIAXONE; COTRIMOXAZOLE; GABAPENTIN; LINEZOLID; METHYLPHENIDATE; VANCOMYCIN; 4 AMINOBUTYRIC ACID; ACETAMIDE DERIVATIVE; AMINE; ANALGESIC AGENT; ANTIINFECTIVE AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; OXAZOLIDINONE DERIVATIVE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; CHILD; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; LONG TERM CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SCHOOL CHILD; SPONDYLITIS; CHEMICALLY INDUCED DISORDER; OSTEOMYELITIS;

ACETAMIDES; AMINES; ANALGESICS; ANTI-BACTERIAL AGENTS; CHILD; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; OSTEOMYELITIS; OXAZOLIDINONES; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 61949483386     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181945999     Document Type: Article

References (13)

1. Arnold SR, Elias D, Buckingham SC, et al. Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant Staphylococcus aureus. J Pediatr Orthop.2006;26:703-708.
2. Birmingham MC, Rayner CR, Meagher AK, et al. Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. Clin Infect Dis.2003;36:159-168.
3. De Vriese AS, Coster RV, Smet J, et al. Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis.2006;42:1111-1117.
4. Chen CJ, Chiu CH, Lin TY, et al. Experience with linezolid therapy in children with osteoarticular infections. Pediatr Infect Dis J.2007;26:985-988.
5. Senneville E, Legout L, Valette M, et al. Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: a retrospective study. Clin Ther.2006;28:1155-1163.
6. Bressler AM, Zimmer SM, Gilmore JL, et al. Peripheral neuropathy associated with prolonged use of linezolid. Lancet Infect Dis.2004;4:528-531.
7. Chao CC, Sun HY, Chang YC, et al. Painful neuropathy with skin denervation after prolonged use of linezolid. J Neurol Neurosurg Psychiatry.2008; 79:97-99.
8. Zivkovic SA, Lacomis D. Severe sensory neuropathy associated with long-term linezolid use. Neurology.2005;64:926-927.
9. Rho JP, Sia IG, Crum BA, et al. Linezolid-associated peripheral neuropathy. Mayo Clin Proc.2004;79:927-930.
10. Ferry T, Ponceau B, Simon M, et al. Possibly linezolid-induced peripheral and central neurotoxicity: report of four cases. Infection.2005;33:151- 154.
11. Park IN, Hong SB, Oh YM, et al. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis. J Antimicrob Chemother.2006;58:701-704.
12. von der Lippe B, Sandven P, Brubakk O. Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)-a report of ten cases. J Infect.2006;52:92-96.
13. Rucker JC, Hamilton SR, Bardenstein D, et al. Linezolid-associated toxic optic neuropathy. Neurology.2006;66:595-598.